Reappraisal of the validity of surgery for patients with pancreatic cancer aged 80 years or older stratified by resectability status

ConclusionPatients aged ≥80 years had a similar prognosis to<80 years in R PDAC, whereas they had significantly worse prognosis in BR/UR PDAC. These findings suggest that surgical resection for patients with PDAC aged ≥80 years is validated in R PDAC, whereas its survival benefit might be limited in BR/UR PDAC.

Source: Journal of Hepato-Biliary-Pancreatic Sciences - October 9, 2019 Category: Gastroenterology Authors: Naru Kondo, Kenichiro Uemura, Naoya Nakagawa, Kenjiro Okada, Shingo Seo, Shinya Takahashi, Yoshiaki Murakami Tags: Original Article Source Type: research